Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential

By Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, K. Tsuji. Stem Cells, 2004

648 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/c307617999bb2092d7ab954b906bc40c309d92eb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Bin Zhang
2. R. C. Lai
3. S. Lim
4. Yijun Yin
5. R. Hass
6. S. S. Tan
7. R. Yeo
8. C. Kasper

Citations in the corpus

• Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. (2013, background): “The ever expanding list of tissues for MSC isolation include adipose tissue [67,68], liver [70], muscle [71], amniotic fluid [72], placenta [73,74], umbilical cord blood [67], dental pulp [75,76], human ESC [78] and other sources [70,77].”
• Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC (2011, background): “Placenta-derived MSC from fetal tissue, including amnion membrane ((AM-MSC) (or HAM; human amniotic membrane)) [21-24], chorion membrane (CM-MSC) [25,26] and chorionic villi (CV-MSC) [27-29] have been have been described as having a more limited life span than MSC populations obtained from the mater”